NAD

NAD Recommends Genomma Modify Current Broadcast Ad for ‘Silka’ to Avoid Certain Comparisons to Other OTC Athlete’s Foot Products

NAD has recommended that Genomma Lab USA, Inc. maker of the athlete’s foot product Silka, modify current advertising claims to eliminate certain comparisons to competing over-the-counter products.

Read More

NAD Recommends SharkNinja Discontinue Certain Claims Challenged by Dyson, Including ‘2-to-1’ Preference Claim

NAD has recommended that SharkNinja Operating, LLC, discontinue the unsupported preference claim that “Americans now choose Shark 2-to-1 over Dyson.”

Read More

KLF International Says it will Discontinue Claims for ‘Venus Factor Weight Loss’ in Response to NAD Inquiry

KLF International, Inc., maker of the Venus Factor Weight Loss System National, has said it will discontinue the advertising claims that were a focus of an NAD inquiry. Venus Factor also committed to monitor its affiliate marketing so that their advertising remained in compliance with the law.

Read More

NAD Refers Advertising for ‘Steuart’s Pain Formula’ To FTC, Following Advertiser’s Failure to Provide Substantiation for Pain-Relief Claims

NAD has referred advertising claims made by Steuart Laboratories, Inc., for its Steuart’s Pain Formula, to the Federal Trade Commission (FTC) for the second time, following the company’s repeated failures to provide substantiation for challenged advertising claims.

Read More

NAD Recommends Bausch & Lomb Discontinue Certain Challenged Claims for Ultra Contact Lenses Following Challenge by J&J Vision Care

NAD has determined that Bausch & Lomb Incorporated can support advertising claims that promote the presence of polyvinylpyrrolidone (PVP), a long-chain polymer with a high molecular weight that attracts and maintains moisture, in the company’s Ultra contact lenses with MoistureSeal Technology.

Read More

NARB Recommends Clarion Brands Modify, Discontinue Claims That Dietary Supplement ‘Lipo-Flavonoid Plus’ Substantially Reduces, Eliminates Tinnitus

A five-member panel of NARB has recommended that Clarion Brands LLC modify or discontinue certain claims for the company’s Lipo-Flavonoid Plus dietary supplement, including claims made through testimonials, that state or imply that the product substantially reduces or eliminates tinnitus and the symptoms of Ménière’s Disease, a disorder of the inner ear.

Read More